TMED2 and lung adenocarcinoma: Feng et al. found that TMED2 knockdown increased apoptosis, inhibited tumor cell proliferation, reduced tumor volume, and decreased tumor biomarker and inflammatory factor levels via TLR4/NF-κB signaling, thereby significantly inhibiting the development of lung adenocarcinoma.